Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

71 results
  1. ... and control for immunological and clinical HIV status, HIV viral replication rates, prior history ... much more research already exists regarding treatment ...
  2. ... S, Parikh U, Heaps A, et al Ultrasensitive HIV-1 drug-resistance analysis in the discover prep trial. Top Antivir ...
  3. ... SJ, Akinbiyi G, et al. High prevalence of HIV drug resistance among newly diagnosed infants aged <18 months: results from a nationwide surveillance in Nigeria. J Acquir Immune Defic Syndr. 2018 01 ... of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants. Pediatr ...
  4. ... 137 , 170 , 172 were identified as having incident HIV infection with a drug resistance mutation. Among patients with incident HIV infection, 1. ... 162 Among 20 patients who were infected with HIV infection and had resistance testing results, an M184V or M184I resistance mutation was ...
  5. ... taking PrEP needed knowledge of the risks involved (HIV, antiretroviral drug resistance) in not adhering to the treatment. The committee ... The committee discussed the risk of antiretroviral therapy resistance in ... of regular HIV testing and the requirement for a negative HIV test ...
  6. ... RD, Tinsley J, Glick SN. A decline in HIV testing among persons who inject drugs in the Seattle area, 2004-2015. J Acquir ... study of initiation of antiretroviral therapy and transmitted drug resistance in ... and young adults with HIV in New York City. Clin Infect Dis. 2014 ...
  7. ... Ponte M, Villahermosa ML, et al.: Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: a UNAIDS study. ...
  8. ... CC, et al. Estimating the rate of accumulating drug resistance mutations in the HIV genome. Value in Health. 2007 May Jun; 10 ( ...
  9. ... al. Clinical features, Outcomes and Molecular Profiles of Drug Resistance in Tuberculous Meningitis in non-HIV Patients. Scientific reports. 2016 Jan 7;6:19072. ...
  10. ... bone metabolism and drug responsiveness) are aimed at testing drug efficacy on bone mass/mineral density, microarchitecture and mechanical resistance in well-controlled conditions. The authors’ review of ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · next · last